The vaccine maker, which has partnered with OpenAI since 2023, is rethinking how it does workforce planning thanks to the ...

The vaccine will only be available to those at high risk from Covid—excluding those who may need it to protect a relative or ...

A combination shot for flu and Covid-19 using messenger RNA generated antibodies in a study, but US government regulators ...

Back in 2024, on May 14, Mad Money’s Jim Cramer was asked about Moderna, Inc. (NASDAQ: MRNA ), explaining that some family ...

The stock might be down substantially over the past three years, but it isn't out of the picture yet. Teladoc Health is a ...

More than 3,000 GPTs are reportedly in use at Moderna, which has partnered with OpenAI. Here's how they're using the technology.

Moderna will merge its technology and HR teams departments, thanks to their increasing reliance on AI and ongoing OpenAI ...

The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.

Learn more about whether Kymera Therapeutics, Inc. or Moderna, Inc. is a better investment based on AAII's A+ Investor grades ...

Moderna, the biotech company behind one of the original mRNA COVID-19 vaccines, is undergoing an AI-powered workplace transformation. In partnership with OpenAI, Moderna has created thousands of ...

MM+M Women of Distinction honoree, announced Monday morning that she has joined Medtronic Diabetes as its chief marketing ...

Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to grant Novavax full approval – without restrictions -- by its April 1 target ...